GENESIS Pharma was one of the first pharmaceutical companies in Europe to specialize in the promotion, sales and distribution of biopharmaceutical products and is currently the largest by turnover among Greek companies focusing on innovative branded medicines for severe and rare diseases. Through long-standing strategic partnerships with some of the leading global pharmaceutical companies committed to cutting-edge R&D, GENESIS Pharma has created a strong product portfolio that includes innovative, high-value pharmaceutical products for multiple sclerosis, rare hematological malignancies and severe forms of cancer. Its portfolio also includes the first drug therapy approved for spinal muscular atrophy, the first oral treatment coming from research in precision medicine for Fabry disease, as well as products in the areas of rheumatology, dermatology and nephrology, including biosimilars. For more information please visit: www.genesispharma.com

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammatory diseases.

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. For more information about Bayer in Greece, go to www.bayer.gr.